Scomnet cashflow strong, margin increased because of the Medical Devices biz , but revenue drop due to automotive cable business during MCO were impacted. Next Quarter report should be better with increasing revenue and profits
UOB Kay Hian upgraded Target Price for Scomnet today (Sept 2) to RM2.40 from RM1.98.
Scomnet is also UOB's alpha stock pick for the month of September. Other 4 alpha stocks are Astro, GENT, Pentamaster and Yinson.
"Embarking on a fantastic 2H20 and beyond. Moving forward, we believe that there will be significant growth in Scomnet’s earnings starting from 2H20, mainly driven by automotive and medical segments"
"Direct beneficiary riding on the soaring demand for COVID-19 related critical medical devices. Beyond this, earnings in FY21 will be supercharged by increased capacity and launching of new products which are listed on the US FDA website" - UOB
Don't forget, Rakuten Trade also has a buy call on Scomnet with a target price of RM2.18 on Aug 17, when the price was RM1.59. Today, price is already close to RM2!
SCOMNET - New major shareholder emerges after the stock surged 520% in less than 6 months
- An off market transaction of 30.8 million shares of Supercomnet Technologies Bhd (Scomnet) was done at RM1.95 on Tuesday, Sept 1.
- This represents a 4.78% stake in the company.
- The counter closed at RM1.95 on the same day, which means the new shareholder did not buy at a discount.
- It is rather unusual for new investors to buy a major block at market price, unless they really trust the company's growth story.
**Scomnet's Growth Story**
- Scomnet is a leading OEM cable manufacturer specialising in medical devices and automative cables and serves large medical device makers in the United States and Germany as well as carmakers like Proton and Perodua, among others.
- UOB KayHian forecasts Scomnet to deliver RM29.5mil net profit for FY20. This would be a 52% jump from the RM19.6mil it delivered in FY19.
- in 1H20, Scomnet has so far delivered some RM10mil. This means, UOB KayHian is anticipating a doubling of earnings in the last two quarter of this year.
- It is also forecasting a net profit of RM51.6mil for FY21. This means a 74% jump in earnings from FY20.
- Scomnet has also secured a new automotive client, which is French car manufacturer PSA Group. PSA Group is the maker of Peugeot and Citroen.
- UOB KayHian is expecting the PSA Group to contribute an incremental 10% to 20% of group revenue from 2021 onwards.
- On the medical devices front, Scomnet has secured 10 new projects with key clients.
- "Incremental revenue from new products (D’Clot Catheter, Colonoscopy GI and Gastroscopy GI which will be in production in 2H20)," says UOB KayHian.
- Scomnet is in the midst of increasing its capacity by 35% within 3 months to fulfil the medical segment's explosive demand.
***BUY Calls***
- 2 research houses have BUY calls on Scomnet namely UOB Kay Hian and Rakuten Trade.
- UOB Kay Hian has on Sept 2 upgraded the Target Price to RM2.40.
- With crazy growth at hand and a growing pipeline of new products, isn't it a matter of time before Scomnet hits net profit of RM100mil?
At that level of earnings, what would Scomnet's share price be like?
Scomnet has also secured a new automotive client, which is French car manufacturer PSA Group. PSA Group is the maker of Peugeot and Citroen.
转至主板可能性非常高!
现金高达RM50 mil !
零负债!没贷款!
赚副预计从15%至18%!
预料2026年里,心血管设备市场规模会达USD 822 亿!!!
全球由5个主要商参与,其中一个就是SCOMNET的大客户!
FY2020 净利料RM28mil, FY2021 净利RM35 mil! Incremental revenue from new products (D’Clot Catheter, Colonoscopy GI and Gastroscopy GI which will be in production in 2H20).
ON TRACK TO DELIVER RECORD EARNINGS WITH ACCELERATED GROWTH IN EPS OF 59% IN FY2020 & 41% IN fy2021.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Dakewlest
1,758 posts
Posted by Dakewlest > 2020-08-26 20:52 | Report Abuse
RM2 soon?